Efficacy of neoadjuvant carboplatin plus docetaxel in triple negative breast cancer: Combined analysis of two cohorts

PURPOSE: Recent studies demonstrate that addition of neoadjuvant (NA) carboplatin (Cb) to anthracycline/taxane chemotherapy improves pathological complete response (pCR) in triple negative breast cancer (TNBC). Effectiveness of anthracycline-free, platinum combinations in TNBC is not well known. Her...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Cancer Res
Auteurs principaux: Sharma, Priyanka, López-Tarruella, Sara, García-Saenz, Jose Angel, Ward, Claire, Connor, Carol S., Gómez, Henry L., Prat, Aleix, Moreno, Fernando, Jerez-Gilarranz, Yolanda, Barnadas, Augusti, Picornell, Antoni C., del Monte-Millán, Maria, Gonzalez-Rivera, Milagros, Massarrah, Tatiana, Pelaez-Lorenzo, Beatriz, Palomero, María Isabel, González del Val, Ricardo, Cortes, Javier, Fuentes, Hugo, Bretel, Denisse, Márquez-Rodas, Iván, Perou, Charles M., Wagner, Jamie L., Mammen, Joshua V., McGinness, Marilee K., Klemp, Jennifer R., Amin, Amanda L., Fabian, Carol J., Heldstab, Jaimie, Godwin, Andrew K., Jensen, Roy A., Kimler, Bruce F., Khan, Qamar J., Martin, Miguel
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5156592/
https://ncbi.nlm.nih.gov/pubmed/27301700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0162
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires